New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation.
In two young patients with acute hepatic porphyria syndrome and persisting paralyses, which increased in intensity during intermittent occurring crisis, the activity of erythrocyte porphobilinogen synthase (delta-aminolevulinic acid dehydratase) was found to be considerably diminished, below 1% of the value of normal control persons. In contrast, the activity of uroporphyrinogen synthase was normal. Both patients have been excreting high quantities of delta-aminolevulinic acid and porphyrins in urine for years. Lead intoxication has definitively been excluded. Since the relatives also show lower activities in porphobilinogen synthase, the disease of these two patients is probably a new enzymatic type of inherited acute hepatic porphyria, the excretion profile of which is qualitatively completely different from those of the known acute porphyrias. The discovery of this porphyria confirms the theory of overlapping transition in the biochemical and clinical symptoms and analogies among acute hepatic porphyrias.
D000208:Acute Disease; D000328:Adult; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D011163:Hydroxymethylbilane Synthase / Q000097:blood; D008107:Liver Diseases / Q000201:enzymology* / Q000235:genetics; D008297:Male; D000623:Porphobilinogen Synthase / Q000172:deficiency*; D011164:Porphyrias / Q000201:enzymology* / Q000235:genetics; D011166:Porphyrins / Q000378:metabolism; D012008:Recurrence; D013577:Syndrome
D011166:Porphyrins; D011163:Hydroxymethylbilane Synthase; D000623:Porphobilinogen Synthase